Abstract

BackgroundThe Multidimensional Prognostic Index (MPI) has been found to predict mortality in patients with a variety of clinical conditions. We aimed to assess the association of the MPI with future mortality and number of in-hospital days for the first time in a population-based cohort.MethodsThe study population consisted of 2472 persons, aged 66–99 years, from the Swedish National Study on Aging and Care in Kungsholmen, Sweden, who underwent the baseline visit 2001–4, and were followed up >10 years for in-hospital days and >12 years for mortality. The MPI was a modified version of the original and aggregated seven domains (personal and instrumental activities of daily living, cognitive function, illness severity and comorbidity, number of medications, co-habitation status, and nutritional status). The MPI score was divided into risk groups: low, medium and high. Number of in-hospital days (within 1, 3 and 10 years) and mortality data were derived from official registries. All analyses were age-stratified (sexagenarians, septuagenarians, octogenarians, nonagenarians).ResultsDuring the follow-up 1331 persons (53.8%) died. Laplace regression models, suggested that median survival in medium risk groups varied by age from 2.2–3.6 years earlier than for those in the corresponding low risk groups (p = 0.002-p<0.001), and median survival in high risk groups varied by age from 3.8–9.0 years earlier than for corresponding low risk groups (p<0.001). For nonagenarians, the median age at death was 3.8 years earlier in the high risk group than for the low risk group (p<0.001). The mean number of in-hospital days increased significantly with higher MPI risk score within 1 and 3 years for people of each age group.ConclusionFor the first time, the effectiveness of MPI has been verified in a population-based cohort. Higher MPI risk scores associated with more days in hospital and with fewer years of survival, across a broad and stratified age range.

Highlights

  • Predicting life expectancy is crucial for clinicians to identify the most appropriate clinical decisions for management, treatment and prevention, as well as for patients to have realistic expectations [1, 2]

  • The effectiveness of Multidimensional Prognostic Index (MPI) has been verified in a population-based cohort

  • Higher MPI risk scores associated with more days in hospital and with fewer years of survival, across a broad and stratified age range

Read more

Summary

Introduction

Predicting life expectancy is crucial for clinicians to identify the most appropriate clinical decisions for management, treatment and prevention, as well as for patients to have realistic expectations [1, 2]. The index has been further validated for all-cause mortality in hospitalized patients with specific acute and chronic diseases [11,12,13,14,15], and in outpatients with cognitive impairment [16]. It has been associated with mortality in nursing home residents [17]. A large prospective multicenter study found that the MPI had significantly better prognostic accuracy in hospitalized older patients than three other frailty indices in predicting mortality [18]. We aimed to assess the association of the MPI with future mortality and number of in-hospital days for the first time in a population-based cohort

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call